Rights and permissions
About this article
Cite this article
Paclitaxel + cisplatin cost effective in NSCLC. Inpharma Wkly. 1206, 6 (1999). https://doi.org/10.2165/00128413-199912060-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199912060-00013